Cancer is one of the leading causes of death in industrialized countries. Age is the main risk factor is followed by unhealthy habits. Its high mortality is mainly due to late diagnosis. At Amadix we are working to develop new tools for prediction and early diagnosis.
On this page, you will find more information about our areas of work, our methodology and our strategy to have an impact on society in order to stop the advance of this global disease.
What cancers do we want to stop?
We work on the early detection of colorectal and lung cancer, the third and second most common cancers worldwide respectively. As well as pancreatic cancer, one of the cancers with the worst prognosis.
Colorectal
cancer
Lung
cancer
Pancreatic
cancer
How do we do it?
We use liquid biopsy (blood sample) and we develop artificial intelligence algorithms based on machine learning for the early detection of cancer. Our approach integrates molecular information from blood and the patient’s clinical information extracted from diagnostic images or their electronic medical records.
Liquid
biopsy
Artificial
intelligence
Where can we have an impact?
Our technology is applicable to screening and health prevention programmes, positioning itself as an additional tool to promote precision personalized medicine aimed at improving oncological diagnosis.
